PRMT5 Promotes EMT Through Regulating Akt Activity in Human Lung Cancer
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in Cell Transplantation
- Vol. 30
Abstract
The type II protein arginine methyltransferase 5 (PRMT5) has been engaged in various human cancer development and progression types. Nevertheless, few studies uncover the biological functions of PRMT5 in the epithelial-mesenchymal transition (EMT) of human lung cancer cells, and the associated molecular mechanisms and signaling cascades are entirely unknown. Here, we show that PRMT5 is the ectopic expression in human lung cancer tissues and cell lines. Further study reveals that silencing PRMT5 by lentivirus-mediated shRNA or blocking of PRMT5 by specific inhibitor GSK591 attenuates the expression levels of EMT-related markers in vivo, using the xenograft mouse model. Moreover, our results show that down-regulation of PRMT5 impairs EGFR/Akt signaling cascades in human lung cancer cells, whereas re-expression of PRMT5 recovers those changes, suggesting that PRMT5 regulates EMT probably through EGFR/Akt signaling axis. Altogether, our results demonstrate that PRMT5 serves as a critical oncogenic regulator and promotes EMT in human lung cancer cells. More importantly, our findings also suggest that PRMT5 may be a potential therapeutic candidate for the treatment of human lung cancer.Keywords
Funding Information
- the Outstanding Clinical Discipline Project of Shanghai Pudong (PWYgy2018-06)
This publication has 24 references indexed in Scilit:
- PRMT5 Promotes Human Lung Cancer Cell Apoptosis via Akt/Gsk3β Signaling Induced by ResveratrolCell Transplantation, 2019
- Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine MethylationCancer Cell, 2019
- PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axisCell Communication and Signaling, 2019
- Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growthJournal of Cellular and Molecular Medicine, 2018
- Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesisJournal of Biological Chemistry, 2018
- Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotencyGenes & Development, 2010
- Methylation of Ribosomal Protein S10 by Protein-arginine Methyltransferase 5 Regulates Ribosome BiogenesisJournal of Biological Chemistry, 2010
- PRMT5 is required for cell-cycle progression and p53 tumor suppressor functionNucleic Acids Research, 2009
- Human SWI/SNF-Associated PRMT5 Methylates Histone H3 Arginine 8 and Negatively Regulates Expression of ST7 and NM23 Tumor Suppressor GenesMolecular and Cellular Biology, 2004